D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ELAN holding history
Elanco Animal Health Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELAN overviewAll 13F holders of ELANFull Q2 2026 holdings
- Shares (Q2 2026)
- 88,993
- Value
- $2.19M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 88,993 | $2.19M | <0.1% | −56,025−38.6% | Reduced | Holders |
| Q1 2026 | 145,018 | $3.47M | <0.1% | +28,050+24.0% | Added | Holders |
| Q4 2025 | 116,968 | $2.65M | <0.1% | −72,436−38.2% | Reduced | Holders |
| Q3 2025 | 189,404 | $3.81M | <0.1% | −25,684−11.9% | Reduced | Holders |
| Q2 2025 | 215,088 | $3.07M | <0.1% | −168,463−43.9% | Reduced | Holders |
| Q1 2025 | 383,551 | $4.03M | <0.1% | −277,088−41.9% | Reduced | Holders |
| Q4 2024 | 660,639 | $8.00M | <0.1% | −367,985−35.8% | Reduced | Holders |
| Q3 2024 | 1,028,624 | $15.1M | <0.1% | −1,502,831−59.4% | Reduced | Holders |
| Q2 2024 | 2,531,455 | $36.5M | 0.1% | −1,756,934−41.0% | Reduced | Holders |
| Q1 2024 | 4,288,389 | $69.8M | 0.1% | −166,587−3.7% | Reduced | Holders |
| Q4 2023 | 4,454,976 | $66.4M | 0.1% | −635,685−12.5% | Reduced | Holders |
| Q3 2023 | 5,090,661 | $57.2M | 0.1% | −4,423,987−46.5% | Reduced | Holders |
| Q2 2023 | 9,514,648 | $95.7M | 0.1% | +1,680,380+21.4% | Added | Holders |
| Q1 2023 | 7,834,268 | $73.6M | 0.1% | −577,953−6.9% | Reduced | Holders |
| Q4 2022 | 8,412,221 | $102.8M | 0.2% | +2,790,134+49.6% | Added | Holders |
| Q3 2022 | 5,622,087 | $69.8M | 0.1% | +3,152,960+127.7% | Added | Holders |
| Q2 2022 | 2,469,127 | $48.5M | 0.1% | −472,315−16.1% | Reduced | Holders |
| Q1 2022 | 2,941,442 | $76.7M | 0.1% | −967,969−24.8% | Reduced | Holders |
| Q4 2021 | 3,909,411 | $110.9M | 0.1% | +2,287,366+141.0% | Added | Holders |
| Q3 2021 | 1,622,045 | $51.7M | 0.1% | −943,974−36.8% | Reduced | Holders |
| Q2 2021 | 2,566,019 | $89.0M | 0.1% | +1,908,455+290.2% | Added | Holders |
| Q1 2021 | 657,564 | $19.4M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.